Altshuler Shaham Ltd Has $45,000 Holdings in CVS Health Co. (NYSE:CVS)

Altshuler Shaham Ltd trimmed its position in CVS Health Co. (NYSE:CVS) by 25.7% in the fourth quarter, HoldingsChannel reports. The firm owned 570 shares of the pharmacy operator’s stock after selling 197 shares during the quarter. Altshuler Shaham Ltd’s holdings in CVS Health were worth $45,000 as of its most recent SEC filing.

Other institutional investors have also added to or reduced their stakes in the company. FMR LLC grew its position in shares of CVS Health by 29.1% during the 3rd quarter. FMR LLC now owns 27,487,238 shares of the pharmacy operator’s stock valued at $1,919,159,000 after acquiring an additional 6,194,441 shares during the period. International Assets Investment Management LLC lifted its stake in shares of CVS Health by 8,697.2% during the 4th quarter. International Assets Investment Management LLC now owns 1,322,129 shares of the pharmacy operator’s stock valued at $104,395,000 after buying an additional 1,307,100 shares in the last quarter. Canada Pension Plan Investment Board lifted its stake in shares of CVS Health by 49.9% during the 3rd quarter. Canada Pension Plan Investment Board now owns 2,095,978 shares of the pharmacy operator’s stock valued at $146,341,000 after buying an additional 698,054 shares in the last quarter. Pacer Advisors Inc. lifted its stake in shares of CVS Health by 12.6% during the 4th quarter. Pacer Advisors Inc. now owns 5,513,230 shares of the pharmacy operator’s stock valued at $435,325,000 after buying an additional 616,785 shares in the last quarter. Finally, J.P. Morgan Private Wealth Advisors LLC purchased a new stake in shares of CVS Health during the 3rd quarter valued at approximately $34,379,000. 80.66% of the stock is owned by institutional investors.

Analysts Set New Price Targets

A number of analysts recently commented on the stock. Bank of America dropped their price target on shares of CVS Health from $95.00 to $77.00 and set a “buy” rating on the stock in a research note on Thursday, May 2nd. Argus lowered their target price on shares of CVS Health from $100.00 to $80.00 and set a “buy” rating on the stock in a research note on Wednesday. TD Cowen cut shares of CVS Health from a “buy” rating to a “hold” rating and lowered their target price for the stock from $99.00 to $59.00 in a research note on Tuesday. Barclays lowered their target price on shares of CVS Health from $78.00 to $63.00 and set an “equal weight” rating on the stock in a research note on Thursday, May 2nd. Finally, UBS Group cut shares of CVS Health from a “buy” rating to a “neutral” rating and lowered their target price for the stock from $85.00 to $60.00 in a research note on Thursday, May 2nd. Nine equities research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $77.67.

Insider Buying and Selling

In related news, EVP Prem S. Shah sold 29,473 shares of the business’s stock in a transaction dated Friday, February 16th. The shares were sold at an average price of $76.95, for a total transaction of $2,267,947.35. Following the sale, the executive vice president now owns 39,765 shares of the company’s stock, valued at $3,059,916.75. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. In related news, EVP Prem S. Shah sold 29,473 shares of the business’s stock in a transaction dated Friday, February 16th. The shares were sold at an average price of $76.95, for a total transaction of $2,267,947.35. Following the sale, the executive vice president now owns 39,765 shares of the company’s stock, valued at $3,059,916.75. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Edward J. Ludwig acquired 1,000 shares of the company’s stock in a transaction that occurred on Thursday, May 2nd. The shares were acquired at an average cost of $53.88 per share, for a total transaction of $53,880.00. Following the purchase, the director now directly owns 21,630 shares of the company’s stock, valued at $1,165,424.40. The disclosure for this purchase can be found here. 0.24% of the stock is currently owned by insiders.

CVS Health Trading Down 1.5 %

Shares of NYSE CVS traded down $0.81 during midday trading on Wednesday, hitting $54.93. 13,618,157 shares of the company traded hands, compared to its average volume of 11,890,314. CVS Health Co. has a 12-month low of $53.70 and a 12-month high of $83.25. The company has a debt-to-equity ratio of 0.78, a quick ratio of 0.61 and a current ratio of 0.81. The stock has a 50-day moving average price of $71.95 and a 200 day moving average price of $73.09. The firm has a market cap of $68.96 billion, a P/E ratio of 9.65, a P/E/G ratio of 0.88 and a beta of 0.56.

CVS Health (NYSE:CVS) last announced its quarterly earnings results on Wednesday, May 1st. The pharmacy operator reported $1.31 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.69 by ($0.38). CVS Health had a net margin of 2.03% and a return on equity of 13.53%. The company had revenue of $88.44 billion for the quarter, compared to analysts’ expectations of $89.33 billion. During the same quarter in the prior year, the firm earned $2.20 EPS. CVS Health’s quarterly revenue was up 3.7% compared to the same quarter last year. As a group, analysts expect that CVS Health Co. will post 7.03 earnings per share for the current year.

CVS Health Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, May 1st. Investors of record on Monday, April 22nd were paid a dividend of $0.665 per share. This represents a $2.66 annualized dividend and a yield of 4.84%. The ex-dividend date was Friday, April 19th. CVS Health’s payout ratio is currently 46.75%.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.